LANGERHANS CELL CHIMERISM AFTER MYELOABLATIVE VERSUS NON-MYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION

被引：0
|
作者：
Kirkorian, Y. [1 ]
Collin, M. [1 ]
Leboeuf, M. [1 ]
Bogunovic, M. [1 ]
Wood, B. [3 ]
Hackman, R. C. [2 ,3 ]
Storer, B. [2 ,3 ]
Storb, R. [2 ,3 ]
Merad, M. [3 ]
Mielcarek, M. [2 ,3 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Univ Washington, Seattle, WA 98195 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    William J. Hogan
    Rainer Storb
    Immunologic Research, 2003, 28 : 1 - 11
  • [42] Non-myeloablative autologous hematopoietic stem cell transplantation for systemic lupus erythematosus
    Statkute, L
    Oyama, Y
    Verda, L
    Barr, WG
    Rosa, R
    Schroeder, J
    Krosnjar, N
    Quigley, K
    Yaung, K
    Villa, M
    Takahashi, MA
    Burt, RK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 9 - 9
  • [43] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    Hogan, WJ
    Storb, R
    IMMUNOLOGIC RESEARCH, 2003, 28 (01) : 1 - 11
  • [44] Analysis of phenotype, function, and chimerism of monocyte-derived dendritic cells after myeloablative vs non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Kircher, B
    Eisendle, K
    Laetzer, K
    Haun, M
    Gruenewald, K
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S198 - S199
  • [45] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
    Schrier, RW
    Parikh, CR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
  • [46] Low incidence of infectious complications after non-myeloablative compared with myeloablative allogeneic stem cell transplantation
    Meijer, E
    Dekker, A
    Lokhorst, H
    Petersen, E
    Nieuwenhuis, K
    BONE MARROW TRANSPLANTATION, 2005, 35 : S198 - S198
  • [47] Incidence of cytomegalovirus infection after allogeneic stem cell transplantation conditioned with myeloablative and non-myeloablative regimens
    Irrera, I
    Morabito, F
    Cuzzola, M
    Cuzzocrea, A
    Iacopino, O
    Penna, G
    Console, G
    Messina, G
    Martino, M
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2003, 31 : S97 - S97
  • [48] Chronic kidney disease after non-myeloablative stem cell transplantation
    Kersting, S.
    Verdonck, L. F.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S81 - S81
  • [49] Non-myeloablative stem cell transplantation for autoimmune diseases
    Burt, RK
    Verda, L
    Oyama, Y
    Statkute, L
    Slavin, S
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 26 (1-2): : 57 - 69
  • [50] Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study
    Gjaerde, Lars I.
    Moser, Claus
    Sengelov, Henrik
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (05)
12345